A phase Ib, open-label, multi-cohort study of metronomic capecitabine plus camre
- This topic has 0 replies, 1 voice, and was last updated 2 years, 6 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
A phase Ib, open-label, multi-cohort study of metronomic capecitabine plus camrelizumab for treatment of refractory solid tumor: McCrest trial.
https://meetings.asco.org/abstracts-presentations/211938
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.